HLB Genex, Inc. (KOSDAQ:187420)
3,010.00
0.00 (0.00%)
Last updated: Aug 12, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Enzymes and Material Business | 35.42B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Enzymes and Material Business Growth | 38.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
New Drug Development | 9.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
New Drug Development Growth | -99.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 1.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -42.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 23.62B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 28.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Netherlands | 4.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Netherlands Growth | 73.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Thailand | 2.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 2.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 169.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom | 738.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom Growth | -62.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -42.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|